Biosynex
Designs and distributes medical diagnostic solutions, including rapid tests and devices.
ALBIO | PA
Overview
Corporate Details
- ISIN(s):
- FR0011005933
- LEI:
- 969500H4BGE1HBLGP566
- Country:
- France
- Address:
- 22 BOULEVARD SEBASTIEN BRANT, 67400 ILLKIRCH-GRAFFENSTADEN
- Website:
- https://www.biosynex.com/en/
- Sector:
- Manufacturing
Description
Biosynex is a company that specializes in the design, manufacture, and distribution of medical diagnostic solutions. Its core product line consists of Rapid Diagnostic Tests (RDTs) for both professional use in clinical settings and for self-testing by the general public. The professional portfolio includes point-of-care (POC) instruments, molecular biology diagnostics (such as PCR tests), and a wide array of immunodiagnostic assays. For the consumer market, Biosynex offers various self-tests and a range of prevention and monitoring devices, including thermometers, blood pressure monitors, and pulse oximeters. The company focuses on providing simple, rapid, and effective tools for screening, diagnosis, and prevention.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-16 07:27 |
Acquisition ou cession des actions de l'émetteur / Descriptif du programme de r…
|
French | 228.7 KB | ||
| 2021-04-15 18:30 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 211.4 KB | ||
| 2021-04-08 19:41 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 172.5 KB | ||
| 2021-04-07 18:00 |
Informations privilégiées / Autres communiqués
|
French | 294.0 KB | ||
| 2021-03-31 18:43 |
Informations privilégiées / Autres communiqués
|
French | 221.5 KB | ||
| 2021-03-24 18:53 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 310.5 KB | ||
| 2021-02-24 18:00 |
Informations privilégiées / Autres communiqués
|
French | 239.6 KB | ||
| 2021-01-29 10:28 |
Inside Information / Other news releases
|
English | 387.3 KB | ||
| 2021-01-29 07:30 |
Informations privilégiées / Autres communiqués
|
French | 443.9 KB | ||
| 2021-01-28 18:15 |
Informations privilégiées / Autres communiqués
|
French | 410.0 KB | ||
| 2021-01-21 18:00 |
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 341.3 KB | ||
| 2021-01-12 18:00 |
Informations privilégiées / Autres communiqués
|
French | 272.6 KB | ||
| 2021-01-11 18:00 |
Informations privilégiées / Autres communiqués
|
French | 221.4 KB | ||
| 2020-12-08 18:00 |
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 173.0 KB | ||
| 2020-12-01 18:17 |
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 261.4 KB |
Automate Your Workflow. Get a real-time feed of all Biosynex filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biosynex
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biosynex via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
